ModernMedicine Resource Center More Topics

Pediatric Immunization Resource Center

Immunization safety in preterm infantsFindings of a new study should alleviate concern that immunization puts preterm infants at risk for clinical deterioration.
Vaccinations: What parents want (VIDEO)For Contemporary Pediatrics, Dr Bobby Lazzara explains key findings from a nationally representative survey published in Clinical Pediatrics. The survey asked parents what they wanted to know about vaccines and how they wanted providers to handle their concerns.
Are physicians missing the chance to recommend HPV vaccines?Physicians who opt against recommending HPV vaccination because they assume their patient is too young or not sexually active, or that the parent will refuse, are missing an opportunity to protect against a dangerous virus, according to a new study.
When 'firing' a patient for vaccine refusal is the only responseOutbreaks of vaccine-preventable diseases like measles and pertussis have led pediatricians to take a hard line, sometimes dismissing patients who are non-compliant with immunizations. A new study examines the prevalence—and consequences—of patient dismissal.
Childhood immunizationsThe currently recommended childhood immunization schedule put forth by the Centers for Disease Control and Prevention (CDC) is designed to protect infants and young children from 14 harmful and potentially deadly diseases before a child’s second birthday.
Maternal H1N1 vaccination and offspring outcomesFindings of a new prospective Swedish population-based cohort study provide further reassurance about the safety of H1N1 vaccination in pregnant women.
PRACTICE MANAGEMENT: The real cost of immunizationMany pediatricians believe that if they pay $30 for an immunization, as long as a payer reimburses them more than $30, they’re OK, said Chip Hart. The fact is, that’s not the case, he explained during his presentation “The Business of Immunization: Protecting Kids without Destroying Your Practice.”
HPV vaccine and pregnancy
HPV vaccine and pregnancyWomen who receive the prophylactic bivalent human papilloma virus (HPV) vaccine within 90 days of pregnancy are not at an increased risk for miscarriage, underscoring the safety of the vaccine. The proven safety of the bivalent HPV vaccine should quell the concerns of women and their health care practitioners.
Hepatitis B vaccination in high-risk infantsThe CDC now recommends that high-risk infants undergo postvaccination serologic testing between 9 and 12 months, updated from 9-18 months. The new vaccination interval can better cover at risk infants from HBV infection and also help ensure a higher adherence to the immunoprophylaxis protocol.
Vaccine refusalIf there is no link between vaccines and conditions such as autism, why do pediatricians spend so much time talking about this topic with parents?